Federated Hermes
INO icon

Federated Hermes’s Inovio Pharmaceuticals INO Stock Holding History

Federated Hermes’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,722
Closed -$3K – 2113
2025
Q4 		$3K Sell
1,722
-623
-27% -$1.37K ﹤0.01% 1940
2025
Q3 		$5.49K Sell
2,345
-4,268
-65% -$8.17K ﹤0.01% 1935
2025
Q2 		$13.5K Buy
6,613
+1,483
+29% +$2.84K ﹤0.01% 1771
2025
Q1 		$8.36K Buy
5,130
+3,517
+218% +$7.06K ﹤0.01% 1832
2024
Q4 		$2.95K Buy
+1,613
New +$7.14K ﹤0.01% 1944
2023
Q2 		– Sell
-261
Closed -$2.56K – 2166
2023
Q1 		$2.56K Buy
261
+151
+137% +$2.57K ﹤0.01% 1988
2022
Q4 		$2.05K Sell
110
-53
-33% -$1.2K ﹤0.01% 2003
2022
Q3 		$4K Sell
163
-43
-21% -$1.1K ﹤0.01% 1910
2022
Q2 		$4K Buy
206
+158
+329% +$4.45K ﹤0.01% 1910
2022
Q1 		$2K Buy
+48
New +$2.16K ﹤0.01% 2026
2020
Q4 		– Sell
-2
Closed -$1K – 2277
2020
Q3 		$1K Sell
2
-8,139
-100% -$1.7M ﹤0.01% 2161
2020
Q2 		$2.63M Buy
8,141
+8,123
+45,128% +$1.3M 0.01% 895
2020
Q1 		$2K Buy
+18
New +$1.11K ﹤0.01% 2018
2019
Q4 		– Sell
-65
Closed -$2K – 2258
2019
Q3 		$2K Sell
65
-282
-81% -$8.57K ﹤0.01% 2031
2019
Q2 		$12K Hold
347
– – ﹤0.01% 1877
2019
Q1 		$16K Sell
347
-8,811
-96% -$444K ﹤0.01% 1808
2018
Q4 		$440K Buy
9,158
+9,024
+6,734% +$548K ﹤0.01% 1462
2018
Q3 		$9K Buy
+134
New +$7.46K ﹤0.01% 1970
2018
Q1 		– Sell
-153
Closed -$8K – 2191
2017
Q4 		$8K Sell
153
-4
-3% -$248 ﹤0.01% 1920
2017
Q3 		$12K Buy
+157
New +$11.7K ﹤0.01% 1818

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's INO Position: Q1 2026 in Review

Federated Hermes sold out of Inovio Pharmaceuticals (INO) in Q1 2026, closing a stake of 1,722 shares — an estimated $3K sold.

Federated Hermes first reported a position in INO in Q3 2017 and held it in 20 quarters. The position peaked at $2.63M in Q2 2020. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Federated Hermes reported no remaining Inovio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Federated Hermes sold 1,722 Inovio Pharmaceuticals shares in Q1 2026, an estimated $3K.
  • Federated Hermes first reported a position in Inovio Pharmaceuticals in Q3 2017 and held it in 20 quarters.
  • Federated Hermes's Inovio Pharmaceuticals position peaked at $2.63M in Q2 2020.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.